King & Spalding LLP

King & Spalding LLP advises industry-leading and start-up clients on a range of life sciences matters, including regulatory work – namely counsel, compliance, investigations, and enforcement – and complex disputes and transactions. Also active in litigation, the firm represents manufacturers in matters related to price control provisions of the Inflation Reduction Act as well as the 340B program. The practice is led by Nikki Reeves, Mark Brown, and Seth Lundy, all FDA regulatory experts based in Washington DC. Also in DC, Brian Bohnenkamp supports clients in fraud and abuse investigations and Lisa Dwyer develops creative FDA regulatory strategies. The team saw significant expansion in 2024, with 11 new partners joining the firm. Among these are Austin-based Kim Bueno and Christopher Cowan as well as Amy Pepke and Tara Blake, both in Houston; all joined from Butler Snow LLP and are experienced in product liability and mass tort trials. Another noteworthy addition to the team is Robert Hur, who returned to the firm’s Washington DC office after serving in several leadership positions at the US Department of Justice.